CML and the WHO: Why? Editorial
| Authors: | Berman, E.; Shah, N. P.; Deninger, M.; Altman, J. K.; Amaya, M.; Begna, K.; Bhatia, R.; Chan, O.; Collins, R.; Curtin, P.; DeAngelo, D. J.; Drazer, M.; Maness, L.; Metheny, L.; Mohan, S.; Moore, J.; Oehler, V.; Pratz, K.; Pusic, I.; Rose, M.; Shomali, W.; Smith, B. D.; Styler, M.; Sweet, K.; Talpaz, M.; Tanaka, T.; Tantravahi, S.; Tsai, S.; Vaughn, J.; Welborn, J.; Yang, D.; Mauro, M.; Cortes, J.; Radich, J.; Druker, B. |
| Title: | CML and the WHO: Why? |
| Keywords: | chronic myeloid leukemia; world health organization; leukemia, myelogenous, chronic, bcr-abl positive; humans; human |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 9 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-03-20 |
| Start Page: | 984 |
| End Page: | 986 |
| Language: | English |
| DOI: | 10.1200/jco.23.01689 |
| PUBMED: | 38086008 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
